Literature DB >> 20080250

Analyzing miRNAs in ductal adenocarcinomas of the pancreas.

Soeren Torge Mees1, Christina Schleicher, Wolf Arif Mardin, Norbert Senninger, Mario Colombo-Benkmann, Joerg Haier.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) have gained attention as an epigenetic component involved in the development of pancreatic ductal adenocarcinoma (PDAC). Several methods for miRNA profiling are in common use, but the validity of these methods is not defined. The aim of this study was to define the optimal method for miRNA detection in PDAC.
METHODS: miRNA expression was determined using different and partially redundant methods (miRNA microarray, TaqMan low density array (TLDA), single tube quantitative RT-PCR). The data from different methods were statistically evaluated and tested for intermethodic consistency and reliability of the results. Finally, the miRNA expression status and the cell lines' ability to metastasize were correlated.
RESULTS: Comparing low and high metastatic cells, miRNA-microarrays identified fewer differentially expressed and only upregulated miRNAs (n=27; 27 up-regulated) compared with TLDAs (n=54; 19 up- and 35 down-regulated). Evaluating miRNAs that target tumor suppressor genes, expression of all single tube quantitative real-time reverse transcriptase PCR (qRT-PCR) validated miRNAs was detected to be significantly altered in TLDA analysis (100%). MiRNA microarrays detected only 25% of qRT-PCR validated miRNAs. Furthermore, results from TLDA analysis correlated well with data from qRT-PCR and presented ΔΔCt values from 3.5±1.86 (range 0.8-5.62) compared with 3.74±1.86 (range 0.78-5.95) in qRT-PCR.
CONCLUSION: Notable differences comparing data obtained from different screening methods were found. While TLDA and qRT-PCR correlated well in quantity and quality of the measured miRNAs, several tumor suppressor gene targeting and down-regulated miRNAs were not detected by miRNA-microarrays. This heterogeneity shows that care must be exercised when comparing results from different methods in PDAC.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080250     DOI: 10.1016/j.jss.2009.10.005

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Aberrant epigenetic grooming of miRNAs in pancreatic cancer: a systems biology perspective.

Authors:  Asfar S Azmi; Frances W J Beck; Bin Bao; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Epigenomics       Date:  2011-12       Impact factor: 4.778

2.  Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs.

Authors:  Hongyan Dong; Martin Paquette; Andrew Williams; R Thomas Zoeller; Mike Wade; Carole Yauk
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

3.  Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer.

Authors:  Yi Tan; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2012-12-06

4.  Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.

Authors:  Birgit Hotz; Ulrike Erben; Marco Arndt; Heinz J Buhr; Hubert G Hotz
Journal:  Int J Colorectal Dis       Date:  2014-09-03       Impact factor: 2.571

5.  MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.

Authors:  Tong Han; Xiao-Ping Yi; Bo Liu; Mu-Jing Ke; Yi-Xiong Li
Journal:  Mol Med Rep       Date:  2015-02-03       Impact factor: 2.952

Review 6.  MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.

Authors:  Tao Xia; Xiao-Yi Chen; You-Ni Zhang
Journal:  Mol Cell Biochem       Date:  2021-07-29       Impact factor: 3.396

7.  Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer.

Authors:  Nikhil Sapre; Matthew K H Hong; Geoff Macintyre; Heather Lewis; Adam Kowalczyk; Anthony J Costello; Niall M Corcoran; Christopher M Hovens
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

8.  Malaria infected red blood cells release small regulatory RNAs through extracellular vesicles.

Authors:  Kehinde Adebayo Babatunde; Smart Mbagwu; María Andrea Hernández-Castañeda; Swamy R Adapa; Michael Walch; Luis Filgueira; Laurent Falquet; Rays H Y Jiang; Ionita Ghiran; Pierre-Yves Mantel
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

Review 9.  MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.

Authors:  Afra Z Daoud; Eoghan J Mulholland; Grace Cole; Helen O McCarthy
Journal:  BMC Cancer       Date:  2019-11-21       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.